Associations of baseline levels of TMAO, choline and L- carnitine with cognitive function over time was estimated using a linear mixed model adjusted for demographics, vascular risk factors (hypertension, atrial fibrillation, diabetes mellitus, dyslipidemia, history of coronary artery disease), life style factors (smoking, body mass index), stroke severity, and ischemic stroke subtype
The UroLift System treatment has demonstrated a significant improvement in quality of life for patients that is greater than reported for medications
Cutaneous lesions and vitamin B12 deficiency
Drugs Medication was administered as described previously (Vukojevic et al., 2018
American Family Physician